BUY Eylea Anti-VEGF Intravitreal Injection Package

BUY Eylea Anti-VEGF Intravitreal Injection Package

EYLEA

EYLEA enables proactive therapy approved for multiple retinal diseases.

EYLEA is the only anti-angiogenic therapy that inhibits vascular endothelial growth factor A (VEGF-A) and Placental Growth Factor (PlGF).

EYLEA's license may allow for a proactive, treat-and-extend dosing approach that is approved for the treatment of:

  • wet age-related macular degeneration (wet AMD),
  • diabetic macular edema (DME), and
  • central retinal vein occlusion (CRVO).

STORE